F. Worden

发表

Safety, pharmacokinetics and preliminary activity of the anti-IGF-IR antibody CP-751,871 in patients with sarcoma

S. Schuetze, P. Haluska, A. Gualberto, 2008 .

Advanced squamous cell carcinoma of the oropharynx: Efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy

K. Frey, S. Mukherji, A. Eisbruch, 2009, Head & neck.

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Thyroid Carcinoma.

R. Seethala, S. Chiosea, Y. Nikiforov, 2017, Archives of pathology & laboratory medicine.

Immune Reactivity Does Not Predict Chemotherapy Response, Organ Preservation, or Survival in Advanced Laryngeal Cancer

L. Dawson, A. Eisbruch, C. Bradford, 2002, The Laryngoscope.

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.

J. Shah, G. Weinstein, R. Weber, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma

G. Hammer, P. Haluska, A. Gualberto, 2010, Cancer Chemotherapy and Pharmacology.

NCCN Task Force Report: mTOR inhibition in solid tumors.

P. Febbo, D. Ettinger, R. Figlin, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer.

A. Eisbruch, N. D’Silva, T. Carey, 2010, Archives of otolaryngology--head & neck surgery.

Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy.

S. Mukherji, A. Eisbruch, C. Bradford, 2006, AJNR. American journal of neuroradiology.

Metronomic dosing of BH3 mimetic small molecule yields robust antiangiogenic and antitumor effects.

Shaomeng Wang, A. Imai, F. Visioli, 2012, Cancer research.

Therapeutics , Targets , and Chemical Biology Metronomic Dosing of BH 3 Mimetic Small Molecule Yields Robust Antiangiogenic and Antitumor Effects

Shaomeng Wang, A. Imai, F. Visioli, 2012 .

One cycle of induction chemotherapy (IC) in advanced oropharyngeal cancer (SCCOP) to select patients for organ preservation (OP)

C. Tsien, A. Eisbruch, T. Carey, 2005 .

NCCN Guidelines ® Insights Head and Neck Cancers , Version 1 . 2018 Featured Updates to the NCCN Guidelines

R. Weber, A. Jimeno, M. Witek, 2018 .

NCCN Guidelines ® Insights Head and Neck Cancers , Version 2 . 2017 Featured Updates to the NCCN Guidelines

Bharat B. Mittal, Jill Gilbert, Loren K. Mell, 2017 .

Association of tobacco (T) use with risk of distant metastases (DM), tumor recurrence, and death in patients (pts) with HPV-positive (+) squamous cell cancer of the oropharynx (SCCOP).

A. Eisbruch, T. Carey, C. Bradford, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mucosal melanoma of the head and neck.

C. Compton, M. Washington, A. Cmelak, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Featured Updates to the NCCN Guidelines

Charles A Enke, James L Mohler, Michael Kuettel, 2013 .

Head and Neck Cancers , Version 1 . 2015 Featured Updates to the NCCN Guidelines

J. Shah, R. Weber, D. Brizel, 2015 .

Head and Neck Cancers, Version 2.2014

Renato Martins, Bharat B. Mittal, Jill Gilbert, 2014 .

Mucosal melanoma of the head and neck.

A. Cmelak, A. Colevas, M. Kies, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Task Force Report: mTOR inhibition in solid tumors.

P. Febbo, D. Ettinger, R. Figlin, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

Chemo-selection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma

C. Tsien, A. Eisbruch, C. Bradford, 2007 .